Volume 15 (2017): Issue 6 (Jun 2017)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxx–xliv
Oncology Research Program
Pages: xlvi
Getting Practical About Recertification
By: Margaret Tempero
Pages: 753
Keeping Up in the Community
By: Daniel P. Mirda
Pages: 754–756
Thrombotic Thrombocytopenic Purpura Associated With Pegylated Interferon Alfa-2a Use in a Patient With Polycythemia Vera
By: Radhika Gangaraju, Soo J. Kim, Jing-Fei Dong, Sabina Swierczek, and Josef T. Prchal
Pages: 757–760
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
By: David Adelstein, Maura L. Gillison, David G. Pfister, Sharon Spencer, Douglas Adkins, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Moon Fenton, Robert L. Foote, Jill Gilbert, Robert I. Haddad, Wesley L. Hicks Jr, Ying J. Hitchcock, Antonio Jimeno, Debra Leizman, William M. Lydiatt, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, James Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Matthew Witek, Frank Worden, Sue S. Yom, Weining Zhen, Jennifer L. Burns, and Susan D. Darlow
Pages: 761–770
Developments in Molecular Testing and Biosimilars
By: Katy Winckworth-Prejsnar, Elizabeth A. Nardi, Lisa Korin Lentz, Jeffrey A. Crawford, C. Lyn Fitzgerald, and Robert W. Carlson
Pages: 772–782
Overuse of Chest CT in Patients With Stage I and II Breast Cancer: An Opportunity to Increase Guidelines Compliance at an NCCN Member Institution
By: Barbara Dull, Andrew Linkugel, Julie A. Margenthaler, and Amy E. Cyr
Pages: 783–789
Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation
By: Juliana E. Hidalgo-López, Rashmi Kanagal-Shamanna, L. Jeffrey Medeiros, Zeev Estrov, C. Cameron Yin, Srdan Verstovsek, Sergej Konoplev, Jeffrey L. Jorgensen, Mohammad M. Mohammad, Roberto N. Miranda, Chong Zhao, John Lee, Zhuang Zuo, and Carlos E. Bueso-Ramos
Pages: 790–796
Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer
By: Caiqian Cropper, Ashley Woodson, Banu Arun, Carlos Barcenas, Jennifer Litton, Sarah Noblin, Diane Liu, Minjeong Park, and Molly Daniels
Pages: 797–803
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
By: Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey Sosman, Mary Dwyer, and Rashmi Kumar
Pages: 804–834
Optimal Surveillance Strategies After Surgery for Renal Cell Carcinoma
By: Mark D. Tyson and Sam S. Chang
Pages: 835–840
Integrating Immunotherapy Into the Management of Renal Cell Carcinoma
By: Matthew Zibelman and Elizabeth R. Plimack
Pages: 841–847
Evidence-Based Guidelines: Optimizing Imaging in Cancer Care
By: Pamela J. DiPiro
Pages: 849–850
  • Collapse
  • Expand